Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment
SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2024--
Source: eagletribune.com
Stay updated with breaking news from Onchille Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO--(BUSINESS WIRE)--Apr 9, 2024--
Onchilles Pharma, a private biotech company developing new pan-cancer therapeutics that leverage a novel mechanism of action, announced today the presentation of preclinical data for the N17350 program at the Society for Immunotherapy of Cancer...